Company intelligence / Profile preview

Jant Group

Encino, California, United Statesdnb.com ↗

Ownership: Private
Development stage: Other

Overview

Jant Pharmacal provides a broad range of point-of-care and laboratory-based diagnostic products. Their offerings include CLIA-waived rapid tests and analyzers for infectious diseases and toxicology, as well as consultation services for lab setup and regulatory compliance. They market under the Accutest® and Accustrip® brands[1][3][10].

Therapeutic areas: Infectious DiseasesOther
Modalities: Diagnostic testDevice
Industry: Protein Biomarker Diagnostics

Partnerships

Vizient (GPO supplier contract)Champs GPO

Beyond the preview

Go deeper on Jant Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jant Group.

Explore the full profile